Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Raphael Pharmaceutical Inc. (RAPH) had Income from Continuous Operations of $-0.22M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-0.23M |
|
-- |
|
-- |
|
$0.22M |
|
$-0.22M |
|
$0.01M |
|
$-0.22M |
|
$-0.22M |
|
$-0.22M |
|
|
Income from Continuous Operations |
$-0.22M |
$-0.22M |
|
$-0.22M |
|
$-0.22M |
|
$-0.22M |
|
20.18M |
|
20.18M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$1.67M |
|
-- |
|
-- |
|
$1.67M |
|
$-1.66M |
|
$-1.66M |
|
$-1.66M |
|
20.18M |
|
| Cash Flow Statement Financials | |
$-0.04M |
|
-- |
|
-- |
|
$0.04M |
|
$0.00M |
|
$-0.04M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-- |
|
-0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
13.06% |
|
13.06% |
|
-7233.33% |
|
13.06% |
|
$-0.08 |
|
$-0.00 |
|
$-0.00 |
|